Pretoria, South Africa

Gerda Fouche

This inventor holds 5 USPTO granted patents and 5 EPO patents. Top assignees: Csir, Korea Institute of Science and Technology. Active years: 2012-2016.


% Patents Active = 80.0

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gerda Fouche: Innovator in Dementia Treatment

Introduction

Gerda Fouche is a prominent inventor based in Pretoria, South Africa. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. With a total of five patents to her name, her work focuses on innovative compositions that aim to prevent or treat cognitive decline.

Latest Patents

Gerda Fouche's latest patents include a composition for preventing or treating dementia that comprises extracts of Monsonia species. This pharmaceutical and food composition is designed to inhibit the formation of β-amyloid, a protein associated with Alzheimer's disease. Another notable patent involves a composition containing arylnaphthalene lignan derivatives, which are aimed at ameliorating memory impairment and improving memory function. These compositions utilize active ingredients such as Justicidin A and 5-methoxyjusticidin A, showcasing her commitment to advancing dementia treatment.

Career Highlights

Throughout her career, Gerda has worked with esteemed organizations such as the Council for Scientific and Industrial Research (CSIR) and the Korea Institute of Science and Technology. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to significant advancements in her field.

Collaborations

Gerda has collaborated with notable colleagues, including Vinesh Jaichand Maharaj and Eric Khorombi. These partnerships have further enriched her research and development efforts in dementia treatment.

Conclusion

Gerda Fouche's work exemplifies the impact of innovation in the medical field, particularly in addressing the challenges of dementia. Her patents reflect a dedication to improving cognitive health and enhancing the quality of life for individuals affected by this condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…